C11085: A Device Associating Rheumatoid Arthritis Subjects with Cardiovascular DiseaseNovelty:
a computer implemented method for determining whether a rheumatoid arthritis patient is at risk for developing cardiovascular disease
Value Proposition:
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by progressive joint deformity. Studies have shown close association between RA and cardiovascular disease (CVD). An estimation of one third to one half RA related deaths are due to CVD and its underlying atherosclerosis. Since the pathogenic features are common to both the atherosclerosis and RA it is difficult to determine patients with risk of CVD. This technology provides methods, systems and media for determining CVD risk in RA patients. This will allow for improved treatment of RA subjects with or at risk for CVD. Other advantages include:
• A newly identified non invasive method which reduces risk and pain for the subject compared to invasive procedures
• Potential of higher accuracy yields compared to invasive procedures
• Shorter diagnosis time
Technical Details:
In a collaborative effort, Johns Hopkins researchers and others have developed an invention consisting of a computer-implemented method for determining whether a rheumatoid arthritis subject is at risk for a cardiovascular disease. The present invention teaches methods, systems and media for analyzing the levels of lipid and lipoprotein analytes in RA subjects which permits determination of risk, diagnosis, and detection of CVD, eg. Atherosclerosis burden.
Looking for Partners:
To develop & commercialize the technology as a tool to detect the RA patients with a risk of associated CVD.
Stage of Development:
Discovery
Data Availability:
Under CDA/NDA
Publications/Associated Cases:
Not available at this time
